KNSAKiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 1-Year High on Analyst Upgrade...

Kornitzer Capital Management Inc. KS purchased a new stake in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 22,091 shares of the comp...

Wall Street Zen raised shares of Kiniksa Pharmaceuticals International from a "hold" rating to a "strong-buy" rating in a report on Monday...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CEO Sanj Patel sold 48,565 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $54.02, for a total transaction of $2,623,481.30. Following the transaction, the...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CEO Sanj Patel sold 22,544 shares of Kiniksa Pharmaceuticals International stock in a transaction dated Wednesday, April...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CEO Sanj Patel sold 2,141 shares of the stock in a transaction on Thursday, April 30th. The shares were sold at an average...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CEO Sanj Patel sold 483,654 shares of Kiniksa Pharmaceuticals International stock in a transaction on Tuesday, April 28th...

Pictet Asset Management Holding SA decreased its stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 15.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 787,520 shares of the company's stock after sel...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) Director Barry Quart sold 13,099 shares of the business's stock in a transaction dated Tuesday, April 28th. The shares were...